Make a donation

Thursday, August 25, 2022

COVID-19 Vaccine Booster, Evusheld Improve Protection for Patients With Blood Cancers

A third dose of a COVID-19 vaccine can prompt seroconversion in patients with hematologic malignancies who failed to seroconvert after 2 doses, according to a study published in Cancer.

Find out more here.